Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.

Sign up for Table of Contents Alerts.

home subscribe search archive forthcoming

Email this page Print this page

Research Paper

The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo

Yan-rong Lu, Yu Yuan, Xiu-jie Wang, Ling-ling Wei, You-nan Chen, Cong Cong, Sheng-fu Li, Dan Long, Wei-dong Tan, Ying-qiu Mao, Jie Zhang, You-ping Li and Jing-qiu Cheng

volume 7 | issue 2

February 2008
Pages: 245 - 253

Purchase article for $19

Subscribe to this journal for $129/year

Mesenchymal stem cells (MSCs) play an important role in the development and growth of tumor cells. The purpose of this study is to confirm the effect of MSCs on tumor cell growth in vitro and in vivo and to elucidate the mechanism. MSCs were isolated from mouse bone marrow and cocultured with murine hepatoma H22, lymphoma (YAC-1 and EL-4) and rat insulinoma INS-1 cell lines. The growth inhibitory effect of MSCs on tumor cells was tested through MTT and 3H-TdR incorporation assay. The apoptosis induction effect of MSCs on tumor cells was assessed with flow cytometry (FCM) and RT-PCR assay. MSCs were inoculated into BALB/c mice alone or coinoculated with ascitogenous hepatoma cells intraperitonealy, respectively. The tumor growth inhibition of MSCs was investigaed through the incidence and volume of ascites formation, and the immunosuppression effect was studied with splenocyte response to ConA stimulation test and T cell subsets analysis (FCM). The results showed that MSCs exhibited a number-dependent growth inhibitory effect on murine tumor cell lines in vitro and inhibited the growth of ascitogenous hepatoma cells in vivo without host immunosuppression. MSCs could upregulate tumor cells mRNA expression of cell cycle negative regulator p21 and apoptosis associated protease caspase 3. The findings of this experimental study demonstrated that MSCs had potential inhibitory effects on tumor cell growth in vitro and in vivo without host immunosuppression, by inducing apoptotic cell death and G0/G1 phase arrest of cancer cells.

Authors

Yan-rong Lu

Key Laboratory of Transplant Engineering and Immunology, Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Yu Yuan

Xiu-jie Wang

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Ling-ling Wei

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

You-nan Chen

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Cong Cong

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Sheng-fu Li

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Dan Long

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Wei-dong Tan

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Ying-qiu Mao

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Jie Zhang

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

You-ping Li

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China

Jing-qiu Cheng

Ministry of Health, West China Hospital, Sichuan University, Chengdu, P. R. China


Purchase article for $19

Subscribe to this journal for $129/year